111 related articles for article (PubMed ID: 21548868)
1. Gastric ulcerogenic and healing impairment actions of alendronate, a nitrogen-containing bisphosphonate - prophylactic effects of rebamipide.
Takeuchi K; Kato S; Amagase K
Curr Pharm Des; 2011; 17(16):1602-11. PubMed ID: 21548868
[TBL] [Abstract][Full Text] [Related]
2. Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide.
Ohashi Y; Aihara E; Takasuka H; Takahashi K; Takeuchi K
J Physiol Pharmacol; 2009 Sep; 60(3):85-93. PubMed ID: 19826186
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.
Aihara E; Hayashi S; Amagase K; Kato S; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):196-202. PubMed ID: 17943251
[TBL] [Abstract][Full Text] [Related]
4. Impairment of gastric ulcer healing by alendronate, a nitrogen-containing bisphosphonate, in rats.
Amagase K; Hayashi S; Nishikawa K; Aihara E; Takeuchi K
Dig Dis Sci; 2007 Aug; 52(8):1879-89. PubMed ID: 17410434
[TBL] [Abstract][Full Text] [Related]
5. Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate.
Amagase K; Inaba A; Senta T; Ishikawa Y; Nukui K; Murakami T; Takeuchi K
J Physiol Pharmacol; 2011 Dec; 62(6):609-18. PubMed ID: 22314563
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of gastric ulcerogenic and healing impairment effects of bisphosphonates: adverse gastric reactions of bisphosphonate.
Takeuchi K; Amagase K
Curr Protoc Toxicol; 2012 Aug; Chapter 21():Unit 21.10.1-29. PubMed ID: 22896009
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine.
Arakawa T; Watanabe T; Fukuda T; Yamasaki K; Kobayashi K
Dig Dis Sci; 1995 Nov; 40(11):2469-72. PubMed ID: 7587834
[TBL] [Abstract][Full Text] [Related]
8. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
Udagawa A; Shiota G; Ichiba M; Murawaki Y
Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
[TBL] [Abstract][Full Text] [Related]
9. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
[TBL] [Abstract][Full Text] [Related]
10. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
[TBL] [Abstract][Full Text] [Related]
11. Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
Naito Y; Yoshikawa T
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):261-70. PubMed ID: 20528113
[TBL] [Abstract][Full Text] [Related]
12. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1995 Oct; 275(1):340-4. PubMed ID: 7562569
[TBL] [Abstract][Full Text] [Related]
14. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action?
Tarnawski A; Arakawa T; Kobayashi K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):90S-98S. PubMed ID: 9753233
[TBL] [Abstract][Full Text] [Related]
16. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
[TBL] [Abstract][Full Text] [Related]
17. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
[TBL] [Abstract][Full Text] [Related]
18. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions.
Takaishi O; Arakawa T; Yamasaki K; Fujiwara Y; Uchida T; Tominaga K; Watanabe T; Higuchi K; Fukuda T; Kobayashi K; Kuroki T
Dig Dis Sci; 1998 Sep; 43(9 Suppl):78S-82S. PubMed ID: 9753231
[TBL] [Abstract][Full Text] [Related]
20. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
